Literature DB >> 31581881

GRM4 inhibits the proliferation, migration, and invasion of human osteosarcoma cells through interaction with CBX4.

Zengliang Zhang1,2, Nan Li1, Xing Wei3, Bingyao Chen1, Yinglong Zhang1, Yantao Zhao1,4, Xiantong Hu1,4, Shuxun Hou1,5.   

Abstract

In recent years, the survey of metabolic glutamate receptor 4 (GRM4) in tumor biology has been gradually concerned. There are currently few studies on GRM4 in osteosarcoma, and the biological function is not clear. Analysis of TCGA database showed that there was no substantial deviation in the expression of GRM4 between osteosarcoma and normal tissues. In the subsequent experiments, there is no significant difference in either mRNA or protein levels among immortalized human osteoblasts and various osteosarcoma cells. With the overexpression of GRM4, cell proliferation, migration and invasion were inhibited obviously. It was further revealed that GRM4 can interact with CBX4 to restrict the nuclear localization of CBX4 and affect the transcriptional activity of HIF-1α. This is the evidence supporting the interaction between GRM4 and CBX4, which could inhibit the malignant behavior of osteosarcoma cells through the GRM4/CBX4/HIF-1α signaling pathway.

Entities:  

Keywords:  CBX4; GRM4; HIF-1α; Osteosarcoma

Mesh:

Substances:

Year:  2019        PMID: 31581881     DOI: 10.1080/09168451.2019.1673147

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  2 in total

1.  Regulation and functional consequences of mGlu4 RNA editing.

Authors:  Christopher S Hofmann; Sheridan Carrington; Andrew N Keller; Karen J Gregory; Colleen M Niswender
Journal:  RNA       Date:  2021-07-08       Impact factor: 5.636

Review 2.  Implications of a Neuronal Receptor Family, Metabotropic Glutamate Receptors, in Cancer Development and Progression.

Authors:  Kevinn Eddy; Mohamad Naser Eddin; Anna Fateeva; Stefano Vito Boccadamo Pompili; Raj Shah; Saurav Doshi; Suzie Chen
Journal:  Cells       Date:  2022-09-13       Impact factor: 7.666

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.